Evidence map›Paper›PMID 39688123›Full record

ArticleThe Medical journal of Australia2025

Classification of chronic kidney disease in older Australian adults by the CKD-EPI 2009 and 2021 equations: secondary analysis of ASPREE study data.

Elisa K Bongetti, Rory Wolfe, James B Wetmore, Anne M Murray, Robyn L Woods, Michelle A Fravel, Mark R Nelson, Nigel P Stocks, Suzanne G Orchard, Kevan R Polkinghorne

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Medical journal of Australia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elisa K BongettiMonash Medical Centre, Melbourne, VIC.
Rory WolfeMonash University, Melbourne, VIC.
James B WetmoreHennepin Healthcare, Minneapolis, MN, United States of America.
Anne M MurrayBerman Center for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Minneapolis, MN, United States of America.
Robyn L WoodsMonash University, Melbourne, VIC.
Michelle A FravelCarver College of Medicine, the University of Iowa, Iowa City, IA, United States of America.
Mark R NelsonMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS.
Nigel P StocksThe University of Adelaide, Adelaide, SA.
Suzanne G OrchardMonash University, Melbourne, VIC.
Kevan R PolkinghorneMonash Medical Centre, Melbourne, VIC.

Funding

ASPirin in Reducing Events in the ElderlyU01AG029824 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI MCNEIL, JOHN JAMES, MURRAY, ANNE M · 2009 to 2018
$64.6M
Monash UniversityNational Health and Medical Research Council 1127060National Health and Medical Research Council 334047National Institute on Aging and the National Cancer Institute (National Institutes of Health) U01AG029824NIA NIH HHS U01 AG029824Victorian Cancer Agency
6 · The paper itself

Abstract

objectivesTo assess the clinical impact on generally healthy older Australians of changing from the 2009 CKD-EPI (CKD-EPI STUDY

designSecondary analysis of data from the prospective ASPirin in Reducing events in the Elderly (ASPREE) cohort study. SETTING,

participantsAustralians aged 70 years or older living in the community and without life-limiting medical conditions, recruited 1 March 2010 - 31 December 2014 for the ASPREE trial.

main outcome measuresBaseline characteristics and long term health outcomes for participants classified to different chronic kidney disease (CKD) stages by CKD-EPI

resultsComplete data were available for 16 244 Australian ASPREE trial participants. At baseline, their mean age was 75.3 years (standard deviation, 4.4 years), and 8938 were women (55%); the median eGFR (CKD-EPI

conclusionsUsing CKD-EPI

Indexed as

Glomerular Filtration RateRenal Insufficiency, ChronicAgedAged, 80 and overAustraliaCreatinineFemaleHumansMaleProspective StudiesCreatinineAgedDiagnostic tests and proceduresEpidemiologic measurementsKidney diseasesPopulation healthPublic healthRenal insufficiency

Identifiers

PMID39688123
PMCPMC12426956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.